- Home
- UAL vs GEHC Comparison
UAL vs GEHC Comparison
Compare UAL & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAL | GEHC |
|---|---|---|
| Founded | 1934 | 1892 |
| Country | United States | United States |
| Employees | 87000 | N/A |
| Industry | Air Freight/Delivery Services | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.8B | 32.1B |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | UAL | GEHC |
|---|---|---|
| Price | $98.79 | $74.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 13 |
| Target Price | ★ $130.59 | $89.23 |
| AVG Volume (30 Days) | ★ 7.8M | 3.0M |
| Earning Date | 04-21-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.19% |
| EPS Growth | ★ 7.94 | 4.84 |
| EPS | ★ 10.20 | 4.55 |
| Revenue | ★ $37,736,000,000.00 | $20,625,000,000.00 |
| Revenue This Year | $10.86 | $7.12 |
| Revenue Next Year | $5.55 | $4.45 |
| P/E Ratio | ★ $9.98 | $16.40 |
| Revenue Growth | 3.23 | ★ 4.84 |
| 52 Week Low | $65.26 | $60.83 |
| 52 Week High | $119.21 | $89.77 |
Technical Indicators
Market Signals| Indicator | UAL | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 54.42 | 52.56 |
| Support Level | $86.54 | $69.59 |
| Resistance Level | $103.43 | $74.83 |
| Average True Range (ATR) | 4.12 | 1.67 |
| MACD | 1.21 | 0.61 |
| Stochastic Oscillator | 64.42 | 74.34 |
Price Performance
Historical ComparisonAbout UAL United Airlines Holdings Inc.
Chicago-based United Airlines is a major US network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel, especially across the Pacific, than its large US peers.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).